Abstract
Genetic and environmental determinants play critical roles in insulin resistance and b-cell function. A model of the complex feedback system for maintenance of glucose tolerance has been developed that reflects the constraint of glycemia within narrow physiologic limits. The "glucose homeostasis" model is described by insulin sensitivity, glucose effectiveness, acute insulin response to glucose, and disposition index (DI). Relatively little is known about the genetic basis of glucose homeostasis phenotypes or their relationship to risk of diabetes and atherosclerotic cardiovascular disease. There is increasing evidence that variation in glucose homeostasis reflects genetic control better than that of commonly used surrogate measures (fasting glucose or fasting insulin). Further, recent linkage scans have identified regions in the human genome that may contain loci that contribute to variation in glucose homeostasis phenotypes. Thus, the prospects are encouraging for positional cloning of genes contributing to glucose homeostasis and providing insight into the nature of the metabolic syndrome and diabetes. Ultimately, knowledge of the genetic basis of glucose homeostasis will facilitate the development of more directed therapies for prevention and treatment of diabetes and other diseases associated with disordered glucose metabolism.
Keywords: genetics, insulin sensitivity, heritability, linkage, disposition index, acute insulin response
Current Diabetes Reviews
Title: The Genetic Basis of Glucose Homeostasis
Volume: 1 Issue: 3
Author(s): Stephen S. Rich and Richard N. Bergman
Affiliation:
Keywords: genetics, insulin sensitivity, heritability, linkage, disposition index, acute insulin response
Abstract: Genetic and environmental determinants play critical roles in insulin resistance and b-cell function. A model of the complex feedback system for maintenance of glucose tolerance has been developed that reflects the constraint of glycemia within narrow physiologic limits. The "glucose homeostasis" model is described by insulin sensitivity, glucose effectiveness, acute insulin response to glucose, and disposition index (DI). Relatively little is known about the genetic basis of glucose homeostasis phenotypes or their relationship to risk of diabetes and atherosclerotic cardiovascular disease. There is increasing evidence that variation in glucose homeostasis reflects genetic control better than that of commonly used surrogate measures (fasting glucose or fasting insulin). Further, recent linkage scans have identified regions in the human genome that may contain loci that contribute to variation in glucose homeostasis phenotypes. Thus, the prospects are encouraging for positional cloning of genes contributing to glucose homeostasis and providing insight into the nature of the metabolic syndrome and diabetes. Ultimately, knowledge of the genetic basis of glucose homeostasis will facilitate the development of more directed therapies for prevention and treatment of diabetes and other diseases associated with disordered glucose metabolism.
Export Options
About this article
Cite this article as:
Rich S. Stephen and Bergman N. Richard, The Genetic Basis of Glucose Homeostasis, Current Diabetes Reviews 2005; 1 (3) . https://dx.doi.org/10.2174/157339905774574293
DOI https://dx.doi.org/10.2174/157339905774574293 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
History and Global Status of the New Coronavirus Covid-2019 and Aspects of Previous Infections of SARS-CoV and MERS-CoV: A Systematic Review
Coronaviruses Novel Therapeutic Approaches in Limiting Oxidative Stress and Inflammation
Current Pharmaceutical Biotechnology Editorial: Vascular Risk Estimation by Specialist Nurses
Current Vascular Pharmacology The Kidney and the Sympathetic System: A Short Review
Current Clinical Pharmacology Recent Advances in Small Animal Cardiac Magnetic Resonance Imaging
Current Cardiology Reviews Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1), a Relevant Target for Diabetic Vasculopathy?
Cardiovascular & Hematological Disorders-Drug Targets Bile Acids and Farnesoid X Receptor: Novel Target for the Treatment of Diabetic Cardiomyopathy
Current Protein & Peptide Science Safety and Efficacy of Aliskiren in the Treatment of Hypertension and Associated Clinical Conditions
Current Drug Safety The Impact of Methodology and Confounding Variables on the Association Between Major Depression and Coronary Heart Disease: Review and Recommendations
Current Psychiatry Reviews Hallmarks in the Therapeutic Approach of Aortic Aneurysms: The Main Contributors
Current Pharmaceutical Design Plasma Glucose Concentrations and Cardiac Hypertrophy in Essential Hypertension
Current Hypertension Reviews Altered Steroid Metabolism and Insulin Signaling in PCOS Endometria: Impact in Tissue Function
Current Pharmaceutical Design Low 25 Hydroxyvitamin D Levels are Independently Associated with Autoimmune Thyroiditis in a Cohort of Apparently Healthy Overweight and Obese Subjects
Endocrine, Metabolic & Immune Disorders - Drug Targets A Critical Approach of Guideline Therapeutic Recommendations for NAFLD
Current Vascular Pharmacology Hypertension in Older Patients
Current Hypertension Reviews Antenatal Maternal Antidepressants Drugs Affect S100B Concentrations in Fetal-Maternal Biological Fluids
CNS & Neurological Disorders - Drug Targets Uric Acid and Hypertension
Current Pharmaceutical Design The Renin-Angiotensin System: New Insight into Old Therapies
Current Medicinal Chemistry Molecular Counting of Captopril by a Microfluidic Chip-Thermal Lens Microscopy System
Current Analytical Chemistry Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside
Current Pharmaceutical Design